132 related articles for article (PubMed ID: 17100242)
1. [Effect of nebivolol on endothelial function in obese patients with hypertension].
Kovaleva ON; Demidenko AV
Lik Sprava; 2006 Jun; (4):57-61. PubMed ID: 17100242
[TBL] [Abstract][Full Text] [Related]
2. [Effects of nebivolol, metoprolol and enalapril maleate on the state of endothelium-dependent arteriolar vasodilation in patients with essential hypertension].
Polivoda SN; Cherepok AA; Solov'iuk AO; Sychev RA; Kurilo OA
Lik Sprava; 2001; (2):138-40. PubMed ID: 11519414
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
[TBL] [Abstract][Full Text] [Related]
4. [Dynamics of a 24-h profile of arterial pressure and function of the vascular endothelium in nebivolol treatment of hypertensive patients].
Gel'tser BI; Kotel'nikov VN
Klin Med (Mosk); 2003; 81(8):53-6. PubMed ID: 14520947
[TBL] [Abstract][Full Text] [Related]
5. [Functional and biochemical characteristics of the vasodilator effects of nebivolol in patients with arterial hypertension].
Gel'tser BI; Kotel'niko v VN; Savchenko SV
Ter Arkh; 2002; 74(12):34-7. PubMed ID: 12577837
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol: impact on cardiac and endothelial function and clinical utility.
Toblli JE; DiGennaro F; Giani JF; Dominici FP
Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol: endothelium-mediated vasodilating effect.
Ritter JM
J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
[TBL] [Abstract][Full Text] [Related]
9. Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.
Merchant N; Searles CD; Pandian A; Rahman ST; Ferdinand KC; Umpierrez GE; Khan BV
J Clin Hypertens (Greenwich); 2009 Dec; 11(12):720-5. PubMed ID: 20021529
[TBL] [Abstract][Full Text] [Related]
10. Early effects of treatment with nebivolol and quinapril on endothelial function in patients with hypertension.
Korkmaz H; Karaca I; Koç M; Onalan O; Yilmaz M; Bilen MN
Endothelium; 2008; 15(3):149-55. PubMed ID: 18568956
[TBL] [Abstract][Full Text] [Related]
11. Use of nebivolol for the treatment of endothelial dysfunction in patients with hypertension: the EDEN registry.
Masoli O; Redruello M; Baliño NP; Grynberg L; Sonia T; Collaud C; Md LV
J Cardiovasc Pharmacol; 2008 Feb; 51(2):202-7. PubMed ID: 18287889
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
Agabiti Rosei E; Rizzoni D
Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
[TBL] [Abstract][Full Text] [Related]
13. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
Pronko TP; Zinchuk VV
Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
[TBL] [Abstract][Full Text] [Related]
14. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension].
Gromnatskiĭ NI; Dius'mikeeva NB
Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053
[TBL] [Abstract][Full Text] [Related]
15. Nebivolol: an endothelium-friendly selective β1-adrenoceptor blocker.
Gao Y; Vanhoutte PM
J Cardiovasc Pharmacol; 2012 Jan; 59(1):16-21. PubMed ID: 21283024
[TBL] [Abstract][Full Text] [Related]
16. [Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974334
[No Abstract] [Full Text] [Related]
17. Nebivolol in obese and non-obese hypertensive patients.
Manrique C; Whaley-Connell A; Sowers JR
J Clin Hypertens (Greenwich); 2009 Jun; 11(6):309-15. PubMed ID: 19527321
[TBL] [Abstract][Full Text] [Related]
18. The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients.
Tarighi B; Kurum T; Demir M; Azcan SN
Can J Cardiol; 2007 Jun; 23(8):651-5. PubMed ID: 17593991
[TBL] [Abstract][Full Text] [Related]
19. Effects of nebivolol on vascular endothelial and myocardial function in diabetes mellitus.
Doggen K; Fransen P; Lemmens K; De Keulenaer GW
J Cardiovasc Pharmacol; 2011 Jul; 58(1):56-64. PubMed ID: 21499118
[TBL] [Abstract][Full Text] [Related]
20. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
Gupta S; Wright HM
Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
